Walmart has reached a settlement with the United States Department of Justice over allegations that its pharmacies contributed to the nationwide opioid epidemic by unlawfully dispensing prescriptions. The Justice Department and Walmart confirmed the agreement on Friday, though the specific terms of the settlement were not disclosed.

The lawsuit, filed in December 2020, was one of the most significant legal actions taken by the Justice Department against a single company concerning the opioid crisis. The government accused Walmart of repeatedly violating the federal Controlled Substances Act since 2013 by failing to identify and report suspicious opioid prescriptions.

In its statement, the Justice Department expressed satisfaction with the resolution, noting that the settlement addresses allegations that Walmart pharmacies did not comply with their obligations regarding the dispensing of opioids and other controlled substances. The department reiterated its commitment to holding accountable entities whose practices exacerbated the opioid crisis. Walmart, in a regulatory filing, stated that it settled for an "immaterial" amount and did not admit liability.

The implications of this settlement are significant, as it marks another major step in the legal efforts to address the devastating impact of the opioid epidemic, which has resulted in hundreds of thousands of deaths in the U.S. While the financial details remain private, the resolution removes a major legal cloud for the retail giant.

The U.S. Centers for Disease Control and Prevention reported that over 905,000 people have died from opioid overdoses in the U.S. between 1999 and 2025. Although annual deaths began to decline after 2022, the crisis continues to be a major public health concern.

This federal lawsuit was separate from other legal actions Walmart has faced. In 2022, the company agreed to pay $3.1 billion to settle numerous lawsuits filed by state and local governments that also alleged its pharmacies played a role in the opioid crisis. Other major drug store chains, such as CVS and Walgreens, have also reached substantial settlements in similar cases.

Walmart has maintained that its pharmacists perform crucial work in patient care. The company stated it is pleased to resolve this matter and will continue to support its pharmacists. A joint stipulation to dismiss the federal case was filed in court on Thursday.

While this particular government lawsuit has been settled, the broader legal landscape surrounding the opioid epidemic remains active, with various entities still facing scrutiny and litigation over their roles in the crisis.